Intrinsic Value of S&P & Nasdaq Contact Us

Nasus Pharma Ltd. NSRX NYSE

NYSE • Healthcare • Biotechnology • IL • USD

SharesGrow Score
46/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$22.00
+895.5%

Stock Statistics — NSRX

Nasus Pharma Ltd. (NSRX) has a market capitalization of $19.03M and trades at $2.21. The 52-week range is 1.98-9.99.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -13, Earnings Per Share (EPS) of $-0.17.

The stock has a beta of -1.70, operates in the Healthcare sector.

Trading Data
Current Price$2.21
52-Week Range1.98-9.99
Volume38.59K
Avg Volume (30D)169.26K
Market Cap$19.03M
Beta (1Y)-1.70
Company
IPO Date2025-08-13
Employees2
CEODan Teleman
CountryIL
ExchangeNYSE
CurrencyUSD
ISINIL0012181553
CUSIP001218155
Income (Latest Year)
EBITDA$-1.52M
Operating Income$-1.08M
Net Income$-1.53M
EPS$-0.17
EPS Diluted$-0.17
Shares Outstanding$9.06M
Balance Sheet (Latest Year)
Valuation Ratios
P/E Ratio-13
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message